Medicover AB (publ)
Informe acción OM:MCOV B
Capitalización de mercado: SEK 27.0b
Medicover Dividendos y recompras
Dividendo controles de criterios 0/6 Medicover es una empresa que paga dividendos con una rentabilidad actual de 0.78%.
Información clave
0.8%
Rentabilidad por dividendo
0%
Rendimiento de la recompra
Rendimiento total para el accionista 0.8% Rendimiento futuro de los dividendos 1.5% Crecimiento de los dividendos 37.4% Próxima fecha de pago de dividendos n/a Fecha ex dividendo n/a Dividendo por acción SEK 0.120 Ratio de pago 91%
Últimas actualizaciones de dividendos y recompras
Upcoming dividend of €0.12 per share Apr 22
Upcoming dividend of €0.12 per share at 0.7% yield Apr 21
Medicover AB (publ) Proposes Dividend for 2022 Feb 18
Mostrar todas las actualizaciones
Insider recently bought kr498k worth of stock Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business Nov 07
Third quarter 2024 earnings released: €0.029 loss per share (vs €0.007 loss in 3Q 2023) Nov 01 Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return Oct 24
Medicover AB (publ) Announces Nomination Committee for the AGM 2025 Oct 02
Medicover AB (publ), Annual General Meeting, Apr 25, 2025 Oct 01
Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024 Aug 14
Second quarter 2024 earnings released: EPS: €0.042 (vs €0.037 in 2Q 2023) Jul 26
Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025 Jul 25
General Legal Counsel recently sold kr1.2m worth of stock Jun 09
Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025 Apr 27
First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023) Apr 26
Upcoming dividend of €0.12 per share Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects Apr 22
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings Apr 04
New minor risk - Earnings quality Mar 30
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet Mar 05
Dividend of €0.12 announced Feb 16
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price Feb 11
Full year 2023 earnings: EPS exceeds analyst expectations Feb 11
Now 24% undervalued Feb 09 Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025
Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024 Jan 09
Consensus EPS estimates increase by 27% Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture Dec 20
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet? Dec 02
Independent Chairman recently bought kr3.9m worth of stock Nov 09
New minor risk - Earnings quality Nov 05
Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025 Nov 05
Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025 Nov 04 Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer Nov 03
Independent Director recently bought kr303k worth of stock Oct 02
Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024 Sep 21
Medicover AB (publ), Annual General Meeting, Apr 26, 2024 Sep 20
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business Sep 12
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet Aug 21
Independent Director recently bought kr1.4m worth of stock Aug 14
Independent Chairman recently bought kr6.3m worth of stock Aug 04
Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022) Jul 27 Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024
Insider recently bought kr242k worth of stock Jun 15
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation? Jun 12
Chief Information Officer recently bought kr321k worth of stock Jun 07
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends May 27
Is Medicover (STO:MCOV B) Using Too Much Debt? May 12
Consensus EPS estimates fall by 10% May 09
Now 21% undervalued after recent price drop Apr 28
Upcoming dividend of €0.12 per share at 0.7% yield Apr 21
Full year 2022 earnings: Revenues in line with analyst expectations Mar 28
Consensus EPS estimates fall by 72% Mar 04
Now 23% undervalued Feb 22
Full year 2022 earnings: Revenues in line with analyst expectations Feb 19
Medicover AB (publ) Proposes Dividend for 2022 Feb 18
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes Feb 16
Consensus EPS estimates fall by 26% Feb 14
Is Medicover (STO:MCOV B) Using Too Much Debt? Jan 30
Investor sentiment improved over the past week Jan 16
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued? Dec 30
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B) Dec 17
Investor sentiment improved over the past week Dec 13
Investor sentiment improved over the past week Nov 10
Third quarter 2022 earnings: Revenues exceed analyst expectations Nov 04 Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger Oct 30
Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023 Oct 22
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet? Oct 16
Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr. Oct 12
Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL. Sep 23 Medicover AB (publ), Annual General Meeting, Apr 27, 2023
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now? Sep 09
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B) Jul 25
Second quarter 2022 earnings: Revenues exceed analyst expectations Jul 22
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet Jul 12
Independent Chairman recently bought kr2.8m worth of stock Jun 17
Medicover AB (publ) (OM:MCOV B) acquired Konzilijum. Jun 14
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B) Jun 13
Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr. Jun 03
High number of new directors May 31
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List? May 29
Chief Information Officer exercised options to buy kr76k worth of stock. May 24
Consensus forecasts updated May 04 Medicover AB (publ) (OM:MCOV B) acquired Kliniki Terapii Allenort Holding Sp. z o.o.
Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: MCOV B no paga un dividendo notable para el mercado Swedish, por lo que no es necesario comprobar si los pagos son estables.
Dividendo creciente: MCOV B no paga un dividendo notable para el mercado Swedish, por lo que no es necesario comprobar si los pagos aumentan.
Rentabilidad por dividendo vs. Mercado Rentabilidad por dividendo de Medicover vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de MCOV B con la del mercado? Segmento Rentabilidad por dividendo Empresa (MCOV B) 0.8% Suelo de mercado 25% (SE) 1.6% Techo de mercado 25% (SE) 4.5% Media de la industria (Healthcare) 1.3% Analista de previsiones (MCOV B) (hasta 3 años) 1.5%
Dividendo destacado: El dividendo de MCOV B(0.78%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Swedish (1.56%).
Alto dividendo: El (0.78%) del dividendo de MCOV B es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Swedish (4.51%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: MCOV B no paga un dividendo notable para el mercado Swedish.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: MCOV B no paga un dividendo notable para el mercado Swedish.
Descubre empresas que pagan buenos dividendos Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
